- Home
- AD vs HIMS Comparison
AD vs HIMS Comparison
Compare AD & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AD | HIMS |
|---|---|---|
| Founded | 1983 | 2017 |
| Country | United States | United States |
| Employees | 4100 | N/A |
| Industry | Telecommunications Equipment | Medical/Nursing Services |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.6B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AD | HIMS |
|---|---|---|
| Price | $48.11 | $16.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 13 |
| Target Price | ★ $55.67 | $26.38 |
| AVG Volume (30 Days) | 210.7K | ★ 31.2M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 68.23% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | ★ $2,347,637,000.00 |
| Revenue This Year | N/A | $19.10 |
| Revenue Next Year | $28.22 | $18.67 |
| P/E Ratio | $275.77 | ★ $28.54 |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $44.03 | $13.74 |
| 52 Week High | $77.13 | $70.43 |
Technical Indicators
Market Signals| Indicator | AD | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 43.23 | 30.28 |
| Support Level | $46.51 | N/A |
| Resistance Level | $50.29 | $59.94 |
| Average True Range (ATR) | 1.41 | 1.26 |
| MACD | -0.05 | 0.35 |
| Stochastic Oscillator | 14.44 | 44.06 |
Price Performance
Historical ComparisonAbout AD Array Digital Infrastructure Inc.
Array Digital Infrastructure, formerly US Cellular, sold its regional wireless operations serving about 4.4 million customers to T-Mobile in August 2025. The firm has agreed to sell most of its remaining spectrum licenses to Verizon and AT&T; however, it will still retain rights to C-band spectrum in several locations after these deals are closed. Array also owns a 5.5% stake in Verizon Wireless' Los Angeles operations and about 4,400 wireless towers.
About HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.